TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IDXX

IDEXX Laboratories Inc

Healthcare · Diagnostics & Research

519.30$ +1.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IDXX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
15.9% 13.5% 18.8% 19.0% 18.1% 19.1% 23.9% 23.5% 16.1% 24.8% 23.8% 27.4%
4.0% 4.3% 4.4% 4.2% 3.8% 3.7% 3.5% 3.3% 3.3% 3.1% 3.3% 3.4%
1.2% 1.2% 1.1% 1.2% 1.1% 1.6% 1.1% 1.2% 1.5% 1.6% 1.5% 1.4%
0.3% 1.5% 1.7% 0.9% 1.4% 2.0% 0.1% 4.6% 0.8% – – –
-0.7% -4.4% 0.2% 0.4% -4.1% -4.4% -1.2% -4.3% -8.1% -2.0% -3.4% -5.3%
4.1% 5.2% 3.6% 3.9% 5.6% 6.4% 4.0% 3.7% 4.4% 3.7% 3.4% 2.9%
-5.4% -19.3% -5.1% -7.0% 6.3% -8.5% -4.0% -9.1% -5.8% -3.4% -5.3% -3.2%
0.0% 0.0% 0.0% 0.0% – 1.5% 1.9% 1.4% – – – –
-41.6% -25.1% -17.1% -14.8% -16.7% -12.5% -6.8% -23.2% -24.3% -2.0% -21.5% -28.3%
31.6% 17.0% 2.1% 2.2% -11.6% -0.4% -3.5% 0.7% 12.8% -11.0% -1.9% -0.7%
-7.0% -6.0% -12.3% -10.6% -27.0% -11.9% -9.2% -21.7% -11.0% -12.1% -22.5% -27.0%
2.9% -12.1% 1.5% 1.7% -2.9% -1.4% 10.8% -7.4% -0.9% 9.3% -4.3% -2.5%
11.8% 8.3% 15.2% 15.1% 12.5% 12.6% 20.0% 19.8% 11.7% 21.1% 20.5% 24.5%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?